The in-depth Hashimoto's resource · part of the Diabetes & Endocrine Specialists network Call 858-622-7200 Request an appointment
The in-depth Hashimoto's resource from Diabetes & Endocrine Specialists

Understanding Hashimoto's — from diagnosis to lifelong management.

The deep-dive companion to our practice: what Hashimoto's is, how it's diagnosed and treated, and how to live with it — written by the endocrinologists who manage it every day, with every recommendation graded honestly by the evidence.

DS
Written by Darius A. Schneider, MD, PhD
President & Medical Director · Board-Certified Endocrinologist (ECNU) · Diabetes & Endocrine Specialists
Featured pathway

"My labs are normal, but I still don't feel well."

Explore this pathway →
hashiexperts.com is the in-depth Hashimoto's resource in the Diabetes & Endocrine Specialists network — the deep companion to our main practice site, focused entirely on this one condition.
Board-certified endocrinologists · physician-scientists
ECNU neck-ultrasound certified
Every page authored by the practice & evidence-graded

Hashimoto's is an immune problem that shows up as a thyroid problem.

The immune system produces antibodies against the thyroid gland. Inflammation follows, and over time the gland loses its ability to make enough hormone. It is the most common cause of hypothyroidism in the United States, and it affects women far more often than men.

Antibodies come first

Many people carry thyroid antibodies for years before thyroid function declines. A positive antibody test is not by itself a reason to start treatment.

Progression varies

Not everyone with antibodies becomes hypothyroid. Some do quickly, some slowly, some never. That is why monitoring matters.

Replacement works

When the thyroid does become underactive, hormone replacement is effective and well established. Most people do well on it.

Symptoms can persist

A minority continue to feel unwell despite normal numbers. That experience is real and warrants a thorough workup.

Every article on this site includes:
Guideline recommendations
Evidence summaries, graded A–E
Clinical controversies
Primary references
Our Method

Test. Treat. Track. In that order.

01

Test

A baseline that goes beyond TSH and free T4 — a full thyroid panel including free T3 and both TPO and thyroglobulin antibodies, plus the micronutrients that genuinely matter in autoimmune thyroid disease: 25-OH vitamin D, selenium, and ferritin.

02

Treat

Interventions prioritized by evidence quality and risk, not by novelty. Correcting a documented deficiency is ordinary good medicine. Adding an unproven supplement because it is fashionable is not.

03

Track

Before starting, we define what success looks like and when we will judge it. We re-measure on schedule using validated instruments. If a therapy is not working, we stop it.

Research-grade discipline

We also run a clinical research center. This is simply how we are trained to think — the same discipline we apply to investigational protocols, brought to routine care.

Evidence, graded honestly

Where widely discussed approaches actually stand.

Patients ask us about these constantly. Here is an honest accounting of each, graded by what the published evidence supports — not by what we would prefer to be true.

Myo-inositol with selenium

Grade B · Moderate
What's shown
The best-supported non-hormonal adjunct: several studies report reductions in TSH and antibody levels in selected patients.
What's unknown
Study populations are specific, effect sizes modest, long-term outcome data limited.
Our position
Reasonable to discuss for selected patients — as an adjunct, never a substitute, with a defined endpoint agreed in advance.

Gut microbiome & the gut–thyroid axis

Grade C · Conflicting
What's shown
The most substantial emerging area — over a hundred studies associate gut microbial composition with Hashimoto's.
What's unknown
Association is not causation. Whether altered flora contributes to disease, or results from it, is unresolved — as is whether changing it changes thyroid outcomes.
Our position
We evaluate gastrointestinal symptoms properly. We do not sell microbiome protocols for thyroid disease.

Individualized T4/T3 therapy

Grade C · Conflicting
What's shown
Conversion of T4 to active T3 varies between individuals, including genetically. The persistently symptomatic patient with a normal TSH is a real problem.
What's unknown
Randomized trials of combination therapy are mixed, and no test reliably identifies who benefits in advance. Over-replacement carries real risk.
Our position
For most, levothyroxine alone is correct. For the symptomatic minority, a carefully monitored trial is legitimate — see Treatment.

Low-dose naltrexone (LDN)

Grade E · Insufficient
What's shown
No published outcome data in Hashimoto's — a point advocates and skeptics agree on. What exists is a plausible mechanism and patient-reported experience.
What's changing
A phase 2 randomized, placebo-controlled trial (ThyroLDN, ACTRN12625000131459) is now underway in exactly this population.
Our position
We do not currently offer LDN for Hashimoto's. When ThyroLDN reports, we will read it carefully and revise our position in either direction.
How we grade evidence. Every intervention carries a plain label — from established, guideline-supported care (A) through moderate (B) and conflicting (C) to experimental (D) and insufficient (E). Mechanistic plausibility is not clinical proof, and we never present an unproven therapy as established.
Why we answer this way
A prescription is not a diagnosis.

It would be easier to offer everything on this page. It would also be easier to dismiss all of it. Neither is honest. The productive middle is to take each question seriously, look at what the evidence actually says, and — if we do try something — measure whether it worked instead of assuming.

Patients deserve a physician who will say "there is no good evidence for that yet" and mean it, and who will also say "this one is worth a trial, and here is how we will know." If you have Hashimoto's and still feel unwell despite normal labs, bring your questions about anything you have read.

San Diego County

Three offices, one standard of care.

Scripps Memorial Campus

La Jolla

9850 Genesee Ave, Suite 470
La Jolla, CA 92037
858-622-7200

Grossmont Campus

La Mesa

8851 Center Drive, Suite 404
La Mesa, CA 91942
619-463-1293

North County Internists

Poway

15525 Pomerado Rd, Suite A1
Poway, CA 92064
858-622-7200

Hashimoto's care is provided by Diabetes & Endocrine Specialists Medical Group.

Ready for thyroid care that takes your questions seriously?

Board-certified endocrinologists. Physician-scientists. Straight answers about what works and what does not.

Call Request Appointment
One San Diego endocrine group, specialized centers: Diabetes & Endocrine Specialists · SanDiEndo — Interventional Endocrinology · MenoExperts — Menopause & Midlife · HashiExperts — Hashimoto's Care · EndoTrials — Clinical Research